Ladenburg Thalmann Financial Services’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $10K | Buy |
60
+27
| +82% | +$4.5K | ﹤0.01% | 4476 |
|
2019
Q3 | $4K | Sell |
33
-63
| -66% | -$7.64K | ﹤0.01% | 4756 |
|
2019
Q2 | $20K | Sell |
96
-366
| -79% | -$76.3K | ﹤0.01% | 4047 |
|
2019
Q1 | $96K | Sell |
462
-40
| -8% | -$8.31K | ﹤0.01% | 2910 |
|
2018
Q4 | $88K | Buy |
502
+335
| +201% | +$58.7K | ﹤0.01% | 2837 |
|
2018
Q3 | $38K | Sell |
167
-33
| -17% | -$7.51K | ﹤0.01% | 3500 |
|
2018
Q2 | $37K | Hold |
200
| – | – | ﹤0.01% | 3460 |
|
2018
Q1 | $37K | Sell |
200
-126
| -39% | -$23.3K | ﹤0.01% | 3460 |
|
2017
Q4 | $70K | Buy |
326
+57
| +21% | +$12.2K | ﹤0.01% | 2995 |
|
2017
Q3 | $58K | Buy |
269
+139
| +107% | +$30K | ﹤0.01% | 2979 |
|
2017
Q2 | $24K | Hold |
130
| – | – | ﹤0.01% | 3494 |
|
2017
Q1 | $32K | Buy |
130
+17
| +15% | +$4.19K | ﹤0.01% | 3232 |
|
2016
Q4 | $29K | Buy |
113
+100
| +769% | +$25.7K | ﹤0.01% | 3230 |
|
2016
Q3 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 4346 |
|